Results 161 to 170 of about 3,754,271 (315)

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

open access: yesMolecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci   +6 more
wiley   +1 more source

Idosos longevos: avaliação da qualidade de vida no domínio da espiritualidade, da religiosidade e de crenças pessoais

open access: yesSaúde em Debate
RESUMO Este estudo tem como objetivo avaliar a qualidade de vida no domínio da espiritualidade, da religiosidade, de crenças pessoais e fatores associados em idosos longevos.
Marília Gabrielle Santos Nunes   +3 more
doaj   +1 more source

An Analysis of Postoperative Complications after Abdominal Surgery in Patients over 80 years of Age

open access: bronze, 1999
Ryouichi Tomita   +4 more
openalex   +2 more sources

Landscape of BRAF transcript variants in human cancer

open access: yesMolecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda   +5 more
wiley   +1 more source

Short- and long-term outcomes of laparoscopic surgery for colorectal cancer in the elderly aged over 80 years old versus non-elderly: a retrospective cohort study [PDF]

open access: gold, 2020
Y. Ueda   +7 more
openalex   +1 more source

WE5.6 Hajibandeh index is more accurate than NELA score in predicting mortality following emergency laparotomy in patients aged over 80 [PDF]

open access: bronze, 2022
Amal Azhar Anwer   +6 more
openalex   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren   +16 more
wiley   +1 more source

“Is Life Worth Living?”: The Role of Masculinity in the Way Men Aged Over 80 Talk About Living, Dying, and Suicide [PDF]

open access: gold, 2020
Kylie King   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy